Rei Hattori, Masanobu Kajiki, Tomomi Fujimoto, Tatsuro Amano, Glen P Kenny, Koichi Watanabe, Takeshi Nishiyasu, Naoto Fujii
{"title":"当NOS被抑制时,TRPA1通道在高温运动中调节皮肤血管舒张。","authors":"Rei Hattori, Masanobu Kajiki, Tomomi Fujimoto, Tatsuro Amano, Glen P Kenny, Koichi Watanabe, Takeshi Nishiyasu, Naoto Fujii","doi":"10.1152/ajpregu.00269.2024","DOIUrl":null,"url":null,"abstract":"<p><p>Nitric oxide synthase (NOS) is an important mediator of cutaneous vasodilation during exercise-heat stress. We recently reported that pharmacological activation of transient receptor potential ankyrin 1 (TRPA1) channel mediates cutaneous vasodilation via NOS-dependent mechanisms under nonheat stress-resting conditions. Here, we hypothesized that TRPA1 channel activation would contribute to cutaneous vasodilation during exercise in the heat via NOS-dependent mechanisms. To assess this response, we first conducted TRPA1 channel antagonist verification substudy (10 young adults and 5 women) wherein 1 mM ASP7663 (TRPA1 channel agonist) increased cutaneous vascular conductance (CVC; cutaneous blood flow divided by mean arterial pressure) and this response was blocked by ∼50% with 100 μM HC030031, a known TRPA1 channel antagonist. Subsequently, 12 young adults (5 women) completed two bouts of 30-min moderate-intensity cycling (45% of their predetermined peak oxygen uptake) in the heat (35°C). During the first exercise, CVC was evaluated at four dorsal forearm skin sites perfused with a 5% DMSO, whereas in the second bout, all sites were treated with either <i>1</i>) a 5% DMSO (control), <i>2</i>) 100 µM HC030031, <i>3</i>) 20 mM l-NAME, a nonselective NOS inhibitor, or <i>4</i>) combination of both. No between-site differences in CVC were measured during the first exercise (<i>P</i> > 0.182). During the second exercise, HC030031 alone had no effect on CVC relative to the control (all <i>P</i> > 0.104). Both l-NAME and HC030031 + l-NAME reduced CVC (all <i>P</i> < 0.001), with the combined treatment showing a greater reduction (all <i>P</i> < 0.001). We showed that TRPA1 channels mediate cutaneous vasodilation during exercise-heat stress only when NOS is inhibited.<b>NEW & NOTEWORTHY</b> We demonstrated that the administration of TRPA1 channel antagonist HC030031 only appears to attenuate cutaneous vasodilation during exercise in the heat when nitric oxide synthase (NOS) is inhibited. TRPA1 channels may function as a \"backup system\" to maintain cutaneous vasodilation when NOS-dependent vasodilation is compromised during exercise in the heat.</p>","PeriodicalId":7630,"journal":{"name":"American journal of physiology. Regulatory, integrative and comparative physiology","volume":" ","pages":"R319-R328"},"PeriodicalIF":2.3000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TRPA1 channels modulate cutaneous vasodilation during exercise in the heat in young adults when NOS is inhibited.\",\"authors\":\"Rei Hattori, Masanobu Kajiki, Tomomi Fujimoto, Tatsuro Amano, Glen P Kenny, Koichi Watanabe, Takeshi Nishiyasu, Naoto Fujii\",\"doi\":\"10.1152/ajpregu.00269.2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Nitric oxide synthase (NOS) is an important mediator of cutaneous vasodilation during exercise-heat stress. We recently reported that pharmacological activation of transient receptor potential ankyrin 1 (TRPA1) channel mediates cutaneous vasodilation via NOS-dependent mechanisms under nonheat stress-resting conditions. Here, we hypothesized that TRPA1 channel activation would contribute to cutaneous vasodilation during exercise in the heat via NOS-dependent mechanisms. To assess this response, we first conducted TRPA1 channel antagonist verification substudy (10 young adults and 5 women) wherein 1 mM ASP7663 (TRPA1 channel agonist) increased cutaneous vascular conductance (CVC; cutaneous blood flow divided by mean arterial pressure) and this response was blocked by ∼50% with 100 μM HC030031, a known TRPA1 channel antagonist. Subsequently, 12 young adults (5 women) completed two bouts of 30-min moderate-intensity cycling (45% of their predetermined peak oxygen uptake) in the heat (35°C). During the first exercise, CVC was evaluated at four dorsal forearm skin sites perfused with a 5% DMSO, whereas in the second bout, all sites were treated with either <i>1</i>) a 5% DMSO (control), <i>2</i>) 100 µM HC030031, <i>3</i>) 20 mM l-NAME, a nonselective NOS inhibitor, or <i>4</i>) combination of both. No between-site differences in CVC were measured during the first exercise (<i>P</i> > 0.182). During the second exercise, HC030031 alone had no effect on CVC relative to the control (all <i>P</i> > 0.104). Both l-NAME and HC030031 + l-NAME reduced CVC (all <i>P</i> < 0.001), with the combined treatment showing a greater reduction (all <i>P</i> < 0.001). We showed that TRPA1 channels mediate cutaneous vasodilation during exercise-heat stress only when NOS is inhibited.<b>NEW & NOTEWORTHY</b> We demonstrated that the administration of TRPA1 channel antagonist HC030031 only appears to attenuate cutaneous vasodilation during exercise in the heat when nitric oxide synthase (NOS) is inhibited. TRPA1 channels may function as a \\\"backup system\\\" to maintain cutaneous vasodilation when NOS-dependent vasodilation is compromised during exercise in the heat.</p>\",\"PeriodicalId\":7630,\"journal\":{\"name\":\"American journal of physiology. Regulatory, integrative and comparative physiology\",\"volume\":\" \",\"pages\":\"R319-R328\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of physiology. Regulatory, integrative and comparative physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1152/ajpregu.00269.2024\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHYSIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of physiology. Regulatory, integrative and comparative physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1152/ajpregu.00269.2024","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
一氧化氮合酶(NOS)是运动-热应激过程中皮肤血管扩张的重要介质。我们最近报道了在非热应激静息条件下,瞬时受体电位锚蛋白1 (TRPA1)通道的药理激活通过nos依赖机制介导皮肤血管舒张。在这里,我们假设TRPA1通道激活会通过nos依赖机制促进热运动时皮肤血管舒张。为了评估这种反应,我们首先进行了TRPA1通道拮抗剂验证子研究(10名年轻人,5名女性),其中1 mM ASP7663 (TRPA1通道激动剂)增加皮肤血管传导(CVC;用已知的TRPA1通道拮抗剂100 μM HC030031阻断该反应约50%。随后,12名年轻人(5名女性)在高温(35°C)下完成了两组30分钟的中等强度骑行(预定峰值摄氧量的45%)。在第一次训练中,用5%DMSO灌注四个前臂背皮肤部位评估CVC,而在第二次训练中,所有部位分别用1)5%DMSO(对照)、2)100μM HC030031、3)20 mM L-NAME(非选择性NOS抑制剂)或4)两者联合处理。在第一次运动时,CVC没有测量位点间差异(P < 0.182)。在第二次练习中,相对于对照组,单独使用HC030031对CVC没有影响(P均为0.104)。L-NAME和HC030031 + L-NAME均能降低CVC (P < 0.05)
TRPA1 channels modulate cutaneous vasodilation during exercise in the heat in young adults when NOS is inhibited.
Nitric oxide synthase (NOS) is an important mediator of cutaneous vasodilation during exercise-heat stress. We recently reported that pharmacological activation of transient receptor potential ankyrin 1 (TRPA1) channel mediates cutaneous vasodilation via NOS-dependent mechanisms under nonheat stress-resting conditions. Here, we hypothesized that TRPA1 channel activation would contribute to cutaneous vasodilation during exercise in the heat via NOS-dependent mechanisms. To assess this response, we first conducted TRPA1 channel antagonist verification substudy (10 young adults and 5 women) wherein 1 mM ASP7663 (TRPA1 channel agonist) increased cutaneous vascular conductance (CVC; cutaneous blood flow divided by mean arterial pressure) and this response was blocked by ∼50% with 100 μM HC030031, a known TRPA1 channel antagonist. Subsequently, 12 young adults (5 women) completed two bouts of 30-min moderate-intensity cycling (45% of their predetermined peak oxygen uptake) in the heat (35°C). During the first exercise, CVC was evaluated at four dorsal forearm skin sites perfused with a 5% DMSO, whereas in the second bout, all sites were treated with either 1) a 5% DMSO (control), 2) 100 µM HC030031, 3) 20 mM l-NAME, a nonselective NOS inhibitor, or 4) combination of both. No between-site differences in CVC were measured during the first exercise (P > 0.182). During the second exercise, HC030031 alone had no effect on CVC relative to the control (all P > 0.104). Both l-NAME and HC030031 + l-NAME reduced CVC (all P < 0.001), with the combined treatment showing a greater reduction (all P < 0.001). We showed that TRPA1 channels mediate cutaneous vasodilation during exercise-heat stress only when NOS is inhibited.NEW & NOTEWORTHY We demonstrated that the administration of TRPA1 channel antagonist HC030031 only appears to attenuate cutaneous vasodilation during exercise in the heat when nitric oxide synthase (NOS) is inhibited. TRPA1 channels may function as a "backup system" to maintain cutaneous vasodilation when NOS-dependent vasodilation is compromised during exercise in the heat.
期刊介绍:
The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology publishes original investigations that illuminate normal or abnormal regulation and integration of physiological mechanisms at all levels of biological organization, ranging from molecules to humans, including clinical investigations. Major areas of emphasis include regulation in genetically modified animals; model organisms; development and tissue plasticity; neurohumoral control of circulation and hypertension; local control of circulation; cardiac and renal integration; thirst and volume, electrolyte homeostasis; glucose homeostasis and energy balance; appetite and obesity; inflammation and cytokines; integrative physiology of pregnancy-parturition-lactation; and thermoregulation and adaptations to exercise and environmental stress.